Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 21, 2026
Syngene International announced the extension of its long-standing strategic collaboration with Bristol Myers Squibb through 2035. The expanded agreement broadens the scope of integrated services across the drug development lifecycle spanning ...
read more
Wednesday, January 21, 2026
Charles River Laboratories International and Gazi University Faculty of Medicine, announced a gene therapy contract development and manufacturing organization (CDMO) collaboration, providing plasmid DNA for AAV production and in vitro efficacy ...
read more
Tuesday, January 20, 2026
Crown Bioscience announced that its San Diego laboratory has achieved College of American Pathologists (CAP) accreditation. This milestone builds on the site’s Clinical Laboratory Improvement Amendments (CLIA) certification, obtained in July 2025, ...
read more
Tuesday, January 20, 2026
WuXi AppTec announced that it has been recognized on the "A List" for leadership in corporate transparency and performance across both Climate Change and Water Security by CDP (Carbon Disclosure Project). This recognition, which represents CDP's ...
read more
Tuesday, January 20, 2026
Alcami has acquired a 37,000-square-foot facility at 4620 Creekstone Drive in Durham, North Carolina. This $6.7 million investment strengthens Alcami's presence in the Research Triangle region and supports the company's continued expansion of ...
read more
Tuesday, January 20, 2026
Worldwide Clinical Trials has entered into a definitive agreement to acquire Catalyst Clinical Research, a specialized oncology CRO, known for early phase oncology trials and a strong biometrics and its Functional Service Provider (FSP) model.
read more
Agno Pharma, a CDMO specializing in small-molecule active pharmaceutical ingredients (APIs) and critical GMP intermediates announced the acquisition of Actylis Eugene, the legacy Cascade Chemistry business based in Eugene, Oregon.
read more
Thursday, January 15, 2026
Vetter has reached several milestones in the development of its next-generation tamper-evident syringe closure system, V-OVS® next, moving the product closer to commercial launch in 2027.
read more
Thursday, January 15, 2026
CluePoints has appointed Sinead Godkin as its new Chief People Officer (CPO). With deep experience scaling global technology organizations through periods of rapid growth, Godkin will lead CluePoints’ people strategy as the company enters its next ...
read more
Thursday, January 15, 2026
Kindeva announced a series of planned leadership transitions designed to position the company for accelerating growth in its core businesses focused on parenteral and inhaled drug delivery.
read more
Thursday, January 15, 2026
Codexis and Axolabs, part of LGC Group, an oligonucleotide CRDMO, announced that they have entered into an agreement under which Axolabs will evaluate Codexis’ ECO Synthesis Manufacturing Platform.
read more
Thursday, January 15, 2026
PSI CRO announced further expansion in Japan, with the opening of the second office located on Level 18 of the Hilton Plaza West Office Tower in Umeda, Kita-ku, Osaka.
read more
Wednesday, January 14, 2026
Symeres announced the appointment of Jurgen Berendsen as Chief Financial Officer (CFO), marking a significant return to the company after a successful tenure as Senior Group Controller.
read more
Tuesday, January 13, 2026
Jubilant Biosys Limited announced the opening of a new discovery and preclinical facility at Noida [Delhi NCR], doubling its overall chemistry capacity for discovery research and scale-up projects.
read more
Tuesday, January 13, 2026
Veristat announced that Kim McLean Boericke has been named Chief Executive Officer (CEO). Boericke, an experienced executive with decades of leadership and operational experience in the clinical research industry, succeeds Patrick Flanagan. After 13 ...
read more